Form D · Pharmaceuticals
ACEA Therapeutics, Inc.
San Diego, CA · CIK 0001734186
Offering snapshot reported Mar 26, 2019 · SEC filing
- Reported sold
- $18M Offering amount: $20M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 15, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 26, 2019 | Initial | $18,000,000 | No comparison | 6 | SEC filing |
| Mar 12, 2018 | Initial | $7,890,500 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-335680
Source: Form D, filed Mar 26, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joyce Hsu | Director |
| Ng Chi Keung | Director |
| Lin Li | Director |
| Feng Lin | Director |
| Jixun Lin | Director |
| Stephen Lin | Director |
| Xiaobo Wang | Director, Executive |
| Xiao Xu | Director, Executive |
| Mang Yu | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6779 Mesa Ridge Road, Suite #100
San Diego, CA, 92121
San Diego, CA, 92121